AA
GRNAW

AQR Arbitrage’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

AQR Arbitrage’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-64,500
Closed -$640K – 1480
2021
Q4 		$640K Hold
64,500
– – 0.02% 810
2021
Q3 		$65K Hold
64,500
– – ﹤0.01% 879
2021
Q2 		$70K Buy
+64,500
New +$57K ﹤0.01% 889

Other funds holding GRNAW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

AQR Arbitrage's GRNAW Position: Q1 2022 in Review

AQR Arbitrage sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q1 2022, closing a stake of 64,500 shares — an estimated $640K sold.

AQR Arbitrage first reported a position in GRNAW in Q2 2021 and held it in 3 quarters. The position peaked at $640K in Q4 2021. 27 funds tracked by Wall St. Rank hold GRNAW as of Q1 2022.

  • AQR Arbitrage reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q1 2022 after selling out during the quarter.
  • AQR Arbitrage sold 64,500 GreenLight Biosciences Holdings, PBC Warrant shares in Q1 2022, an estimated $640K.
  • AQR Arbitrage first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q2 2021 and held it in 3 quarters.
  • AQR Arbitrage's GreenLight Biosciences Holdings, PBC Warrant position peaked at $640K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q1 2022.

Based on AQR Arbitrage's 13F filing for Q1 2022, filed 16 May 2022.